title: Efficacy of budesonide in combination  with formoterol in patients with  inadequately controlled asthma on  fluticasone in combination  with salmeterol.
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Kanemitsu
authors.forename: Hideo
authors.initials: H
authors.lastname: Kita
authors.forename: Akio
authors.initials: A
authors.lastname: Niimi
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Fuseya
authors.forename: Kazuya
authors.initials: K
authors.lastname: Tanimura
authors.forename: Yuko
authors.initials: Y
authors.lastname: Katayama
authors.forename: Tamaki
authors.initials: T
authors.lastname: Takahashi
authors.forename: Yukimasa
authors.initials: Y
authors.lastname: Hatachi
authors.forename: Yumi
authors.initials: Y
authors.lastname: Nishihara
authors.forename: Toshikatsu
authors.initials: T
authors.lastname: Sado
mesh_terms: D000420:Albuterol / Q000031:analogs & derivatives / Q000627:therapeutic use; D000730:Androstadienes / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D019819:Budesonide / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004983:Ethanolamines / Q000627:therapeutic use*; D000068298:Fluticasone; D000068759:Formoterol Fumarate; D006801:Humans; D000068299:Salmeterol Xinafoate; D016896:Treatment Outcome
chemical_list: D000730:Androstadienes; D018927:Anti-Asthmatic Agents; D004983:Ethanolamines; D019819:Budesonide; D000068299:Salmeterol Xinafoate; D000068298:Fluticasone; D000420:Albuterol; D000068759:Formoterol Fumarate